What is the Genesystem Co., Ltd. stock price forecast?

Genesystem Co., Ltd. is currently trading at ₩3,860. View real-time AI analysis on Alpha Lenz.

What is Genesystem Co., Ltd. insider trading activity?

View the latest insider trading data for Genesystem Co., Ltd. on Alpha Lenz.

What is Genesystem Co., Ltd.'s P/E ratio?

Genesystem Co., Ltd.'s P/E ratio is -2.7.

Genesystem Co., Ltd.

KRX · 363250

₩3,860+100(+2.66%)Market closed

Ask about Genesystem Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Genesystem Co., Ltd. trades at a P/E of -2.7 (undervalued) with modest ROE of -88.2%.”

Ask for details →

Company Overview

Genesystem Co., Ltd. is a biotechnology company specializing in the development and commercialization of innovative diagnostic solutions. The primary focus of the company is to provide advanced molecular diagnostic systems that assist in the rapid and accurate detection of various diseases. Notably, the company has expanded its expertise into areas like infectious diseases, genetic disorders, and cancer diagnostics, providing healthcare professionals with essential tools for early intervention and precise treatment strategies. Its contributions are pivotal in enhancing the capabilities of laboratories and hospitals by streamlining diagnostic workflows and improving patient outcomes. Headquartered in South Korea, Genesystem Co., Ltd. stands out in the biotechnology industry for its commitment to research and development, consistently pushing the boundaries of diagnostic technologies in the global healthcare market.

CEO서유진

Websitehttps://www.genesystem.co.kr

SectorHealthcare

IndustryDiagnostics & Research

Employees54

Company Statistics

FY 2025

Profile

₩32,842,354,520Market Cap

₩381,356,660Revenue

8.51MShares Out

54Employees

Margins

-646.35%Gross

-2253.35%EBITDA

-2540.06%Operating

-4172.23%Pre-Tax

-3846.55%Net

Valuation

-2.75P/E

4.18P/B

86.12EV/Sales

-4.15EV/EBITDA

-4.55P/FCF

Growth (CAGR)

-52.91%Rev 3Yr

-50.82%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-66.23%ROA

-88.15%ROE

-71.27%ROIC

Financial Health

₩1,112,357,390Cash & Cash Equivalents

₩5,535,785,960Net Debt

85.81%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Genesystem Co., Ltd. trades at a P/E of -2.7 (undervalued) with modest ROE of -88.2%.”

Ask for details →

Frequently Asked Questions

Genesystem Co., Ltd. (ticker: 363250) is a company listed on KRX in the Healthcare sector (Diagnostics & Research). It has approximately 54 employees. Market cap is $32.8B.

The current price is ₩3,860 with a P/E ratio of -2.75x and P/B of 4.18x.

ROE is -88.15% and operating margin is -2540.06%. Annual revenue is $381M.